Jeffrey Allen Bailey, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 4,557 shares at $8.43 ($38K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
Open-market sale of $38k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| THQ | BUY | 2020-09-23 | $10K | — | Filing → |
| THW | BUY | 2020-09-23 | $10K | — | Filing → |
| HQL | BUY | 2020-09-23 | $10K | — | Filing → |